BACKGROUND: Cell-mediated immune (CMI) responses to hepatitis C virus (HCV) antigens in adults without seroconversion or viremia are biomarkers for prior transient infection. We investigated HCV-specific CMI responses in seronegative children living with HCV-infected siblings. METHODS: Children 3-18 years of age living with HCV-infected siblings were screened for HCV antibodies and HCV RNA. Peripheral blood mononuclear cells (PBMCs) were evaluated for HCV-specific CMI responses by interferon γ (IFN-γ) enzyme-linked immunospot assay using 3 recombinant HCV protein antigens. Flow cytometry phenotypically characterized IFN-γ-secreting cells. RESULTS: Forty-five seronegative children and 5 seropositive viremic siblings had functionally viable PBMCs. Among the 45 seronegative siblings, 15 (33.3%) had positive HCV-specific IFN-γ responses, and subsequent RNA testing revealed that 3 were viremic. Compared with the 5 seropositive viremic children, the median number of HCV-specific spot-forming units was significantly higher in the 12 seronegative aviremic children (P = .002) and in the 3 seronegative viremic children (P = .025). Flow cytometric analysis revealed that IFN-γ was synthesized mainly by CD4(+) T cells. CONCLUSION: Strong HCV-specific CD4(+) T cell responses were detectable in higher frequency among seronegative, aviremic children compared with persistently infected siblings. Further studies are needed to determine whether these immune responses are protective against HCV infection.
BACKGROUND: Cell-mediated immune (CMI) responses to hepatitis C virus (HCV) antigens in adults without seroconversion or viremia are biomarkers for prior transient infection. We investigated HCV-specific CMI responses in seronegative children living with HCV-infected siblings. METHODS:Children 3-18 years of age living with HCV-infected siblings were screened for HCV antibodies and HCV RNA. Peripheral blood mononuclear cells (PBMCs) were evaluated for HCV-specific CMI responses by interferon γ (IFN-γ) enzyme-linked immunospot assay using 3 recombinant HCV protein antigens. Flow cytometry phenotypically characterized IFN-γ-secreting cells. RESULTS: Forty-five seronegative children and 5 seropositive viremic siblings had functionally viable PBMCs. Among the 45 seronegative siblings, 15 (33.3%) had positive HCV-specific IFN-γ responses, and subsequent RNA testing revealed that 3 were viremic. Compared with the 5 seropositive viremic children, the median number of HCV-specific spot-forming units was significantly higher in the 12 seronegative aviremic children (P = .002) and in the 3 seronegative viremic children (P = .025). Flow cytometric analysis revealed that IFN-γ was synthesized mainly by CD4(+) T cells. CONCLUSION: Strong HCV-specific CD4(+) T cell responses were detectable in higher frequency among seronegative, aviremic children compared with persistently infected siblings. Further studies are needed to determine whether these immune responses are protective against HCV infection.
Authors: G Missale; R Bertoni; V Lamonaca; A Valli; M Massari; C Mori; M G Rumi; M Houghton; F Fiaccadori; C Ferrari Journal: J Clin Invest Date: 1996-08-01 Impact factor: 14.808
Authors: P Scognamiglio; D Accapezzato; M A Casciaro; A Cacciani; M Artini; G Bruno; M L Chircu; J Sidney; S Southwood; S Abrignani; A Sette; V Barnaba Journal: J Immunol Date: 1999-06-01 Impact factor: 5.422
Authors: U Dittmer; M Spring; H Petry; T Nisslein; P Rieckmann; W Lüke; C Stahl-Hennig; G Hunsmann; W Bodemer Journal: J Biotechnol Date: 1996-01-26 Impact factor: 3.307
Authors: S Mazzoli; D Trabattoni; S Lo Caputo; S Piconi; C Blé; F Meacci; S Ruzzante; A Salvi; F Semplici; R Longhi; M L Fusi; N Tofani; M Biasin; M L Villa; F Mazzotta; M Clerici Journal: Nat Med Date: 1997-11 Impact factor: 53.440
Authors: K R Fowke; N J Nagelkerke; J Kimani; J N Simonsen; A O Anzala; J J Bwayo; K S MacDonald; E N Ngugi; F A Plummer Journal: Lancet Date: 1996-11-16 Impact factor: 79.321
Authors: Anthony J Freeman; Rosemary A Ffrench; Jeffrey J Post; Charles E Harvey; Stuart J Gilmour; Peter A White; George Marinos; Ingrid van Beek; William D Rawlinson; Andrew R Lloyd Journal: J Infect Dis Date: 2004-08-10 Impact factor: 5.226
Authors: Camilla S Graham; Michael Curry; Qi He; Nezam Afdhal; David Nunes; Catherine Fleming; Robert Horsburgh; Donald Craven; Kenneth E Sherman; Margaret James Koziel Journal: Hepatology Date: 2004-07 Impact factor: 17.425
Authors: Kenneth E Sherman; Jeremie Guedj; Mohamed Tarek Shata; Jason T Blackard; Susan D Rouster; Mario Castro; Judith Feinberg; Richard K Sterling; Zachary Goodman; Bruce J Aronow; Alan S Perelson Journal: Sci Transl Med Date: 2014-07-23 Impact factor: 17.956
Authors: Mona M Rafik; Alaa El-Dien M S Hosny; Khaled O Abdallah; Amal A Abbas; Rania A Abo Shady; Dina A Soliman; Khaled M Nasr El-Din Rakha; Shahira F Alfedawy Journal: Virol J Date: 2013-05-11 Impact factor: 4.099
Authors: Samer S El-Kamary; Mohamed Hashem; Doaa A Saleh; Sayed F Abdelwahab; Maha Sobhy; Fatma M Shebl; Michelle D Shardell; G Thomas Strickland; Mohamed Tarek Shata Journal: J Pediatr Date: 2012-08-09 Impact factor: 4.406